New

Oncoshot

The AI engine Fit Assessment

Beta

Oncoshot develops digital solutions that leverage AI technology and operates within the pharmaceutical industry to facilitate clinical trials.

Blurb

Oncoshot helps patients, caregivers and oncologists find cancer clinical trials anywhere in the world.

HQ Location

Singapore (Singapore)

Founded

2018

Employees

11 - 50

Total funding raised

$2.36M

Funding Status

Seed, $900.00K, October 13, 2022

Oncoshot was founded in 2018 by Medical Oncologist Dr Huren Sivaraj and Data Science Engineer Ruslan Enikeev. As a health insights exchange platform, Oncoshot leverages its proprietary clinical trial matching artificial intelligence technology to address the inefficiencies of cancer clinical trials. The platform serves as a bridge between leading regional healthcare institutions and contract research organizations and global biotechnology and pharmaceutical companies to facilitate data-driven cancer clinical trials while accelerating enrolment into actively recruiting ones.